Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
04/1997
04/02/1997EP0765390A1 Alpha-lactalbumin gene constructs
04/01/1997US5616483 Genomic DNA sequences encoding human BSSL/CEL
04/01/1997US5616473 Used to modify lignin in pulp operations
03/1997
03/25/1997CA2050479C Cd3 specific recombinant antibody
03/19/1997EP0763114A2 Hepatitis g virus and molecular cloning thereof
03/19/1997CN1145168A In ovo vaccination against coccidiosis
03/12/1997EP0760848A1 Lactobacillus strains of human origin, their compositions and uses thereof
03/11/1997US5610048 Xylanase, DNA sequences, coding for the xylanases and methods of use thereof
03/11/1997CA1338981C Biologically active proteins and a method for their production
03/06/1997WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/06/1997WO1997008196A1 Neurturin and related growth factors
03/06/1997CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/04/1997CA1338957C Avirulent microbes and uses therefor
02/1997
02/19/1997CN1034054C Preparing method for improved oligosaccharide conjugate vaccines
02/05/1997CN1142247A Extracorporeal ceel culture and transplantation kits
01/1997
01/22/1997CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs
01/21/1997US5595868 Monoclonal antibodies to hepatitis C virus
01/03/1997WO1997000326A1 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/1996
12/31/1996US5589169 Topical application of tissue plasminogen activator
12/27/1996WO1996041811A1 Magnetic pigment
12/27/1996EP0749472A1 Extracorporeal cell culture and transplantation kits
12/27/1996EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical
12/27/1996EP0625190B1 New bacterium causing poultry disease and vaccine derived thereof
12/27/1996CA2607563A1 Magnetic particles with a glass surface and their use
12/27/1996CA2605671A1 Magnetic particles with a glass surface and their use
12/27/1996CA2161391A1 Stable transformation
12/24/1996US5587497 19-nor-vitamin D compounds
12/19/1996WO1996040916A1 Icam-4 materials and methods
12/19/1996WO1996040234A1 In ovo vaccination against coccidiosis
12/19/1996CA2332731A1 Oligonucleotide tags for sorting and identification
12/19/1996CA2288401A1 Icam-4 materials and methods
12/18/1996EP0748631A2 Viral vaccines
12/12/1996DE19520398A1 Magnetic particles with, opt. porous, glass surface
12/11/1996CN1137806A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/03/1996US5581476 Computer-based methods and articles of manufacture for preparing G-CSF analogs
12/03/1996CA2028140C Novel bacteriocin compositions for use as enhanced broad range
11/1996
11/28/1996WO1996037624A1 A method for producing influenza hemagglutinin multivalent vaccines
11/19/1996US5576003 Ornithobacterium rhinotracheale vaccine and method of immunization
11/14/1996WO1996035782A1 Il-6 activity inhibitor
10/1996
10/30/1996CN1134727A 阿拉伯木聚糖降解酶 Arabinoxylan degrading enzyme
10/29/1996US5569833 Over-expression of nitrate reductase
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996012737A3 Compositions and treatment for multiple sclerosis
10/09/1996CN1133049A Melanona-inhibiting protein
10/02/1996EP0734443A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
10/02/1996CN1132527A G-CSF analogue compsn. and its prepn. method
10/01/1996US5561236 Plant cell into which a gene has been introduced, the expression of which inhibits the antibiotic and herbicidal effects of bialaphos and phosphinothricin
10/01/1996US5561123 Antitumor agents, anticarcinogenic agent
09/1996
09/19/1996WO1996021463A3 New applications of lysozyme dimer
09/18/1996CN1131438A Protein having TPO activity
09/11/1996EP0730653A1 Arabinoxylan degrading enzymes
08/1996
08/29/1996WO1996026278A1 HUMAN DNase I VARIANTS
08/22/1996CA2211938A1 Psychrophilic protease and psychrophilic bacteria
08/21/1996EP0726943A1 Activated factor xiii
07/1996
07/31/1996CN1128046A Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
07/30/1996US5541293 Consensus human leukocyte interferon
07/30/1996US5541071 Assay for identifying antagonists of gastrin and CCK-B receptors
07/25/1996CA2210798A1 Plant growth stimulating composition
07/23/1996CA1338469C Cloning and expression of ligninase
07/18/1996WO1996021463A2 New applications of lysozyme dimer
07/18/1996CA2210091A1 New applications of lysozyme dimer
07/10/1996EP0720649A1 Novel xylanase, process for producing the same, method for the treatment of pulp, and production of xylo-oligosaccharides
06/1996
06/26/1996CN1125466A Processes for producing an enzyme
06/26/1996CN1032142C Expression of factor seventh and ninth activities in mammalian cells
06/25/1996US5529919 Method of making endoglucanase I
06/19/1996EP0495852B1 Modified biological material
06/13/1996WO1996017956A2 Method of detection of nucleic acids with a specific sequence composition
06/13/1996CA2206127A1 Method of detection of nucleic acids with a specific sequence composition
06/12/1996EP0463151B1 Generation of xenogeneic antibodies
05/1996
05/29/1996EP0713915A1 Hog cholera virus vaccine and diagnostic
05/29/1996CN1123144A 3-substituted-2-oxindoles as inhibitors of viral replication
05/28/1996US5520788 Support layer for enzyme electrode laminated membranes
05/23/1996WO1996015106A1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
05/22/1996EP0712273A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
05/22/1996EP0461144B1 Process and means for the microbiological remediation of polluted soil and microorganisms for use in said process
05/15/1996EP0711349A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
05/08/1996EP0710719A1 Generation of xenogeneic antibodies
05/08/1996EP0710248A1 Melanoma-inhibiting protein
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996WO1996012737A2 Compositions and treatment for multiple sclerosis
05/02/1996CA2203629A1 Compositions and treatment for multiple sclerosis
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/01/1996EP0709459A2 Modified biological material
04/1996
04/25/1996WO1996011952A1 Method for purifying keratinocyte growth factors
04/18/1996WO1996011269A2 Tie-2 ligands, methods of making and uses thereof
04/11/1996WO1996006935A3 Arabinoxylan degrading enzymes
03/1996
03/27/1996EP0702719A1 Process for the sterilization of biological compositions and the product produced thereby
03/27/1996EP0549617B1 Improved vaccine compositions
03/07/1996WO1996006935A2 Arabinoxylan degrading enzymes
03/07/1996WO1995032291A3 Hepatitis g virus and molecular cloning thereof
03/07/1996CA2174844A1 Arabinoxylan degrading enzymes
03/06/1996EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer
03/06/1996EP0699079A1 Bioactive and/or targeted dendrimer conjugates
03/06/1996EP0699073A1 Allogeneic and xenogeneic transplantation
02/1996
02/28/1996EP0698116A1 Processes for producing an enzyme
02/18/1996CA2156120A1 3-substituted-2-oxindoles as inhibitors of viral replication
02/15/1996CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
02/13/1996US5491088 Genetic engineering
02/07/1996EP0695355A1 Protein having tpo activity
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100